View All Key Stats
LLY Key Stats
| Income Statement | |
| Revenue (TTM) | 22.00B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.31 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 2.447B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 73.36% |
| Profit Margin (Quarterly) | 17.31% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 2.40% |
| Price and Valuation | |
| Market Cap | 94.97B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.154 |
| PE Ratio (TTM) | 37.34 |
| Price to Book Value | 6.735 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.8731 |
| Free Cash Flow (Quarterly) | 1.430B |
| Return on Equity (TTM) | 16.91% |
View All LLY News
LLY News
-
WireHeadlineTime (ET)
-
Yahoo10/17 10:36
-
Yahoo10/17 09:07
-
SA Breaking News10/16 14:58
-
PR Newswire10/16 14:45
-
SA Breaking News10/16 12:29
-
Yahoo10/16 10:58
-
Yahoo10/16 10:38
-
Yahoo10/16 09:07
-
Yahoo10/16 07:38
-
MT Newswires10/16 07:21
View All Events
LLY Events
| Date | Type | Description |
|---|---|---|
| 10/24/2018 | Misc | Eli Lilly and Co Third Quarter Earnings Conference Call in 2018 |
| 10/24/2018 | Earnings | Eli Lilly and Co Third Quarter Earnings Results in 2018 |
| 07/25/2018 | Misc | Eli Lilly and Co Second Quarter Earnings Conference Call in 2018 |
| 07/25/2018 | Earnings | Eli Lilly and Co Second Quarter Earnings Results in 2018 |
| 05/01/2018 | Misc | Eli Lilly and Co Annual General Meeting in 2017 |
| 04/25/2018 | Misc | Eli Lilly and Co First Quarter Earnings Conference Call in 2018 |
| 04/25/2018 | Earnings | Eli Lilly and Co First Quarter Earnings Results in 2018 |
| 01/31/2018 | Misc | Eli Lilly and Co Fourth Quarter Earnings Conference Call in 2017 |
| 01/31/2018 | Earnings | Eli Lilly and Co Fourth Quarter Earnings Results in 2017 |
| 10/24/2017 09:00 EDT | Misc | Eli Lilly and Co Third Quarter Earnings Conference Call in 2017 |
LLY Fundamentals
Income Statement View Statement
LLY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
LLY One Page Reports
- One Page Report Download
LLY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 86.26 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.lilly.com
- Investor Relations URL: https://investor.lilly.com/
- HQ State/Province: Indiana
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Growth
- Next Earnings Release: Oct. 24, 2017
- Last Earnings Release: Jul. 25, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Aug. 11, 2017
- Description: Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
LLY Comparables
EditLLY Excel Add-In Codes
- Name: =YCI("LLY","name")
- Description: =YCI("LLY","description")
- Sector: =YCI("LLY","sector")
- Industry: =YCI("LLY","industry")
- Est. Current Fiscal Year End: =YCI("LLY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other LLY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- LLY Tweets Stocktwits
Advertisement
